KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Interest Expenses (2018 - 2025)

Elanco Animal Health's Interest Expenses history spans 8 years, with the latest figure at $80.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 73.91% year-over-year to $80.0 million; the TTM value through Dec 2025 reached $220.0 million, down 6.38%, while the annual FY2025 figure was $220.0 million, 6.38% down from the prior year.
  • Interest Expenses for Q4 2025 was $80.0 million at Elanco Animal Health, up from $52.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $80.0 million in Q4 2025 and bottomed at $40.0 million in Q1 2025.
  • The 5-year median for Interest Expenses is $60.5 million (2021), against an average of $60.4 million.
  • The largest annual shift saw Interest Expenses surged 281.25% in 2021 before it crashed 39.39% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $55.0 million in 2021, then rose by 12.73% to $62.0 million in 2022, then rose by 8.06% to $67.0 million in 2023, then plummeted by 31.34% to $46.0 million in 2024, then soared by 73.91% to $80.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Interest Expenses are $80.0 million (Q4 2025), $52.0 million (Q3 2025), and $48.0 million (Q2 2025).